Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson to Participate in Barclays Global Healthcare Conference

PR Newswire March 3, 2016

A Winning Dividend ETF Idea For March

Benzinga.com  March 3, 2016

Federman & Sherwood Announces Jury Verdict Against Johnson & Johnson

Business Wire February 29, 2016

Love This Low Volatility Dividend ETF

Benzinga.com  February 25, 2016

New Dividend ETF Proves To Be A Worthy Hideout

Benzinga.com  February 18, 2016

Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa

Press Releases February 17, 2016

Johnson & Johnson to Participate in RBC Capital Markets Global Healthcare Conference

PR Newswire February 9, 2016

How To Invest In An Aging World With The 'Live Long & Prosper' ETF

Benzinga.com  February 8, 2016

A Checkup On A Big Healthcare ETF

Benzinga.com  February 5, 2016

Seeking Value, Growth and Momentum -- Analyst Notes on Comcast, Coca-Cola, Johnson & Johnson and 3M

Accesswire February 4, 2016

Warm Up With This Low Volatility ETF

Benzinga.com  February 1, 2016

Johnson & Johnson Reports 2015 Fourth-Quarter Results:

PR Newswire January 26, 2016

Johnson & Johnson Joins First Industry-wide Call for New Collective Action to Address Antimicrobial Resistance

PR Newswire January 20, 2016

Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace

PR Newswire January 19, 2016

Dividend Aristocrats ETF Joins The $1 Billion Club

Benzinga.com  January 15, 2016

Janssen and Johnson & Johnson to Provide Webcast Presentation on the Janssen Oncology Hematologic Malignancy Portfolio

PR Newswire January 15, 2016

Write A Prescription For This Healthcare ETF

Benzinga.com  January 15, 2016

11 Different Ways To Play The Bear Market (From 11 Traders)

Benzinga.com  January 14, 2016

For This Low Vol ETF, It's Not All About Sector Selection

Benzinga.com  January 8, 2016

Johnson & Johnson Partners with Leading Universities to Advance Women's Education in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D)

PR Newswire January 6, 2016